Using GnuWin32 to add missing GNU tools for Claude Code on Windows

On October 25, 2026, a post titled "Filling in the GNU tools for Claude Code on Windows with GnuWin32" appeared on cnblogs.com. It opens by describing a class of failures the author kept running into when using Claude Code on Windows: the claude command itself installs fine and launches fine, but the moment a task needs grep, sed, find or awk, the run either errors out or behaves oddly. The author places the blame on the environment rather than on the tool: Claude Code runs in a Unix-like command line by default, and the native Windows command line was never built with that toolchain in place.

The post then turns to Claude Code's own documentation, which concedes that on Windows the product needs Git for Windows, which provides bash plus a bundle of GNU tools, or PowerShell as the shell, in order to work properly. Because the author did not want to install a full Git Bash setup or enable WSL just for this, GnuWin32 is offered as the lighter remedy. As the article describes it, GnuWin32 is a collection of standalone native Windows ports of individual GNU tools, taking grep, sed, find, awk and coreutils one by one and turning them into native executables that do not sit on top of Cygwin and do not require a complete Unix-like runtime. Each utility is normally distributed as its own installer or zip, and once installed it shows up as a .exe that can be called straight from cmd or PowerShell, with grep, sed, make and wget among the packages available.

The recommended procedure is to use GetGnuWin32 and install only the core packages you actually need, such as coreutils, grep, sed, findutils and gawk, rather than pulling in a full Git Bash distribution or turning on WSL. The closing line of the piece sums up the value proposition: Claude Code needs these tools, GnuWin32 supplies exactly those tools, and nothing more. As of the report, the post had laid out the symptom, the official documentation's position and the character of the GnuWin32 solution, with no follow-up developments described.